Secondly, for the pooled risk ratio in the users of ACE inhibitors (RR 0.99, 95% CI 0.78–1.20) and ARBs (RR 0.89, 95% CI 0.77–1.02), we cannot conclude the hypothesis that ACE inhibitors and ARBs reduce the risk of PD. Here, ACE is linked to Parkinson disease.